Clinical Trial Update: A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Famitinib in patients with Gastrointestinal Stromal Tumor is ongoing, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Famitinib (Famitinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gastrointestinal Stromal Tumor | Phase 2 | Status: UNKNOWN